As of 13 July 2021, BNP Paribas received the necessary approvals and acquired 100% of Exane, raising its stake from the 50% previously held during a successful 17-year partnership. This transaction will further strengthen and widen the range of cash equities (execution and research) and derivatives services BNP Paribas can offer to institutional investors and corporates globally.
BNP Paribas Corporate and Institutional Banking (CIB) is a globally recognised leader offering tailored financial solutions for corporate and institutional clients, including capital markets issuance, securities services, financing, treasury, advisory solutions, risk management and hedging. By matching the financing needs of companies with the investment opportunities sought by institutional investors, BNP Paribas CIB's financial solutions create value while contributing to the financing of the economy. Click here for more information about BNP Paribas CIB.
Note: BNP Paribas and Exane are working closely towards a seamless and smooth transition, which includes the sharing of certain client information, in line with each entity's regulatory requirements.
Under the brand name BNP Paribas Exane, Cash Equities provides institutional investors with a full range of Execution, Research, Sales and Corporate Access services.
Exane Solutions has developed a complete range of products and services for asset managers, wealth managers and private bankers.
Exane's asset management business is built around its asset management company Exane Asset Management.
BNP Paribas Exane was awarded Best Large-Cap Provider and Best User Experience in the Algorithmic Trading category during The Trade Leaders in Trading 2022 award ceremony in London on 2nd November.
In this year's Institutional Investor Survey 2022, BNP Paribas Exane once again delivers an excellent performance and was ranked #1 for Industry Research in Europe.
From 14 to 16 June, BNP Paribas Exane was very happy to be able to hold its 24th CEO Conference in person for the first time in 3 years.
Once again, BNP Paribas Exane earns the top overall ranking from long-only investors, against a volatile market backdrop.
On 25th January, BNP Paribas Exane and BNP Paribas hosted a workshop on "Impact Share Buyback as an ESG Instrument" during the IR 22 Virtual Week virtual event.
Exane BNP Paribas has been ranked No.1 Best Access To Market and No.1 Overall Outperformer in the Algorithmic Trading category at the Leader in Trading 2021 awards ceremony.
Exane BNP Paribas expands its equity Research team for companies in Germany, Austria and Switzerland with three senior analysts. The team will be led by Ingo Schachel, previously Head of Equity Research at Commerzbank.
In the context of the development of its asset management business, the Kepler Cheuvreux Group has signed the acquisition of the asset management company Ellipsis AM. The transaction remains subject to the prior approval of the French Financial Markets Authority and is expected to be completed in the fourth quarter 2021.
Exane BNP Paribas has once again confirmed its leading Cash Equities position, being at the top of the rankings for the 5th consecutive year.
The Exane Pleiade Performance fund (Exane Asset Management) of has received the "Globe d'Argent" award (second position) in the absolute return category, during the "Globes de la Gestion 2021" ceremony organized by the French magazine Gestion de Fortune.
As of 13 July 2021, BNP Paribas received the necessary approvals and acquired 100% of Exane, raising its stake from the 50% previously held during a successful 17-year partnership.